标题
The Gut-Bone Axis in Diabetes
作者
关键词
-
出版物
Current Osteoporosis Reports
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-11-28
DOI
10.1007/s11914-022-00767-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment
- (2022) Maria Buur Nordskov Gabe et al. PHARMACOLOGICAL RESEARCH
- Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
- (2022) Thomas Karagiannis et al. DIABETOLOGIA
- GIP Affects Hepatic Fat and Brown Adipose Tissue Thermogenesis but Not White Adipose Tissue Transcriptome in Type 1 Diabetes
- (2022) Sebastian Møller Nguyen Heimbürger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The role of incretins on insulin function and glucose homeostasis
- (2021) Jens Juul Holst et al. ENDOCRINOLOGY
- Evaluation of the risk of fracture in type 2 diabetes mellitus patients with incretins: an updated meta-analysis.
- (2021) Qing-xin KONG et al. Endokrynologia Polska
- Effects of endogenous GIP in patients with type 2 diabetes
- (2021) Signe Stensen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Antiresorptive Effect of GIP , But Not GLP ‐2, Is Preserved in Patients With Hypoparathyroidism—A Randomized Crossover Study
- (2021) Kirsa Skov‐Jeppesen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The evolving story of incretins ( GIP and GLP ‐1) in metabolic and cardiovascular disease: A pathophysiological update
- (2021) Michael A. Nauck et al. DIABETES OBESITY & METABOLISM
- Exendin(9‐39) NH 2 : Recommendations for clinical use based on a systematic literature review
- (2021) Lærke Smidt Gasbjerg et al. DIABETES OBESITY & METABOLISM
- The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial
- (2021) Sebastian M. N. Heimbürger et al. DIABETOLOGIA
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus
- (2021) Sundeep Khosla et al. Nature Reviews Endocrinology
- Differences in the roles of types 1 and 2 diabetes in the susceptibility to the risk of fracture: a systematic review and meta-analysis
- (2021) Jiaqing Dou et al. Diabetology & Metabolic Syndrome
- Associations between Postprandial Gut Hormones and Markers of Bone Remodeling
- (2021) Nina Wittorff Jensen et al. Nutrients
- Effects of GLP-1 Receptor Agonists on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus: A 52-Week Clinical Study
- (2021) Ting-ting Cai et al. Biomed Research International
- Glucose variability and low bone turnover in people with type 2 diabetes
- (2021) Jakob Starup-Linde et al. BONE
- Subcutaneous GIP and GLP-2 inhibit nightly bone resorption in postmenopausal women: A preliminary study
- (2021) Kirsa Skov-Jeppesen et al. BONE
- Effects of short‐acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes
- (2021) Nicklas J. Johansen et al. DIABETES OBESITY & METABOLISM
- Effects of Anti-Diabetic Drugs on Fracture Risk: A Systematic Review and Network Meta-Analysis
- (2021) Yu-Sheng Zhang et al. Frontiers in Endocrinology
- Loss of Function Glucose-Dependent Insulinotropic Polypeptide Receptor Variants Are Associated With Alterations in BMI, Bone Strength and Cardiovascular Outcomes
- (2021) Hüsün Sheyma Kizilkaya et al. Frontiers in Cell and Developmental Biology
- No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes
- (2020) Natasha C. Bergmann et al. DIABETES CARE
- Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus
- (2020) X. X. Liu et al. Journal of Diabetes Research
- GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
- (2020) Michael A. Nauck et al. Molecular Metabolism
- Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
- (2020) Laurie L. Baggio et al. Molecular Metabolism
- Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
- (2020) Jonathan E. Campbell Molecular Metabolism
- Separate and Combined Gluco-Metabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 in Healthy Individuals
- (2019) Lærke S. Gasbjerg et al. DIABETES
- Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis
- (2019) Hao Wang et al. BMJ Open
- Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men without Diabetes
- (2019) Natasha Chidekel Bergmann et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study
- (2019) Natasha C. Bergmann et al. DIABETOLOGIA
- Glucagon‐like peptide‐1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials
- (2019) Liang Cheng et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Glucagon-like peptide-1 receptor agonists and fracture risk—limitations to current knowledge
- (2019) K. Hygum et al. OSTEOPOROSIS INTERNATIONAL
- Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies
- (2019) K. Hidayat et al. OSTEOPOROSIS INTERNATIONAL
- GIP-induced vasodilation in human adipose tissue involves capillary recruitment
- (2019) Meena Asmar et al. Endocrine Connections
- Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial
- (2019) Rahim M Naimi et al. Lancet Gastroenterology & Hepatology
- GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men
- (2019) Kirsa Skov-Jeppesen et al. BONE
- The diurnal variation of bone formation is attenuated in adult patients with type 2 diabetes
- (2019) Katrine Hygum et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- PYY is a negative regulator of bone mass and strength
- (2019) Victoria D. Leitch et al. BONE
- Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists
- (2019) Lærke S. Gasbjerg et al. PEPTIDES
- GIP and the gut-bone axis – Physiological, pathophysiological and potential therapeutic implications
- (2019) Signe Stensen et al. PEPTIDES
- GIP’s effect on bone metabolism is reduced by the selective GIP receptor antagonist GIP(3–30)NH2
- (2019) Lærke S. Gasbjerg et al. BONE
- Bone resorption is unchanged by liraglutide in type 2 diabetes patients: A randomised controlled trial
- (2019) Katrine Hygum et al. BONE
- Bone turnover: Biology and assessment tools
- (2018) Pawel Szulc BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose
- (2018) Henrik Maagensen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Emerging therapeutic potential for peptide YY for obesity-diabetes
- (2018) Ryan A. Lafferty et al. PEPTIDES
- Incretin-based therapy for the treatment of bone fragility in diabetes mellitus
- (2018) Guillaume Mabilleau et al. PEPTIDES
- The Activity of Peptides of the Calcitonin Family in Bone
- (2018) Dorit Naot et al. PHYSIOLOGICAL REVIEWS
- MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover – a systematic review and meta-analysis
- (2017) Katrine Hygum et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia
- (2017) Mikkel B Christensen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability
- (2017) P. Szulc et al. OSTEOPOROSIS INTERNATIONAL
- Insulin Plays a Permissive Role for the Vasoactive Effect of GIP Regulating Adipose Tissue Metabolism in Humans
- (2016) Meena Asmar et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Does Diet-Induced Weight Loss Lead to Bone Loss in Overweight or Obese Adults? A Systematic Review and Meta-Analysis of Clinical Trials
- (2015) Jessica Zibellini et al. JOURNAL OF BONE AND MINERAL RESEARCH
- GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women
- (2015) Eva W. Iepsen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effects of acute hyperinsulinemia on bone metabolism
- (2015) Kaisa K Ivaska et al. Endocrine Connections
- Glucose-Dependent Insulinotropic Polypeptide Inhibits Bone Resorption in Humans
- (2014) Anne Nissen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Functional Amino Acid Substitution in the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Gene Is Associated With Lower Bone Mineral Density and Increased Fracture Risk
- (2014) S. S. Torekov et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?
- (2014) W. D. Leslie et al. OSTEOPOROSIS INTERNATIONAL
- Physiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2
- (2013) Daniel J. Drucker et al. Annual Review of Physiology
- The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
- (2013) David M. Nathan et al. DIABETES CARE
- Effect of glucagon-like peptide-2 exposure on bone resorption: Effectiveness of high concentration versus prolonged exposure
- (2012) Carsten Askov-Hansen et al. REGULATORY PEPTIDES
- The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes
- (2011) Asger Lund et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans
- (2011) M. Christensen et al. DIABETES
- Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes
- (2011) Ann V. Schwartz JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Physiological Variations in Circulating Insulin Levels on Bone Turnover in Humans
- (2011) Rita Basu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucose-Dependent Insulinotropic Polypeptide May Enhance Fatty Acid Re-esterification in Subcutaneous Abdominal Adipose Tissue in Lean Humans
- (2010) M. Asmar et al. DIABETES
- Four-month treatment with GLP-2 significantly increases hip BMD
- (2009) Dennis B. Henriksen et al. BONE
- Short bowel syndrome: the role of GLP-2 on improving outcome
- (2009) Katharina Wallis et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Reduced attenuation of bone resorption after oral glucose in type 2 diabetes
- (2008) La-or Chailurkit et al. CLINICAL ENDOCRINOLOGY
- The cell biology of bone metabolism
- (2008) H K Datta et al. JOURNAL OF CLINICAL PATHOLOGY
- Reduction in bone resorption by exogenous glucagon-like peptide-2 administration requires an intact gastrointestinal tract
- (2008) Ida B. Gottschalck et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome
- (2008) Ida B. Gottschalck et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search